ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HAE Haemonetics Corp

94.40
1.07 (1.15%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Haemonetics Corp NYSE:HAE NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  1.07 1.15% 94.40 94.785 93.09 94.52 368,663 01:00:00

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2021 Results: May 13, 2021

23/04/2021 9:05pm

PR Newswire (US)


Haemonetics (NYSE:HAE)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Haemonetics Charts.

BOSTON, April 23, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish fourth quarter and fiscal year 2021 financial results at 6:00 am EDT on Thursday, May 13, 2021. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EDT on May 13, 2021. 

The call can be accessed with the following information:

U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
Conference ID required for access: 8694785

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/xqyzme3t

A replay of the conference call and webcast will be available for one year beginning on May 13, 2021 at 11:00 a.m. ET using the conference call webcast link provided in this press release.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.  

 

Investor Contact:

Media Contact:

Olga Guyette, Director-Investor Relations

Carla Burigatto, VP-Global Communications

(781) 356-9763

(781) 348-7263

olga.guyette@haemonetics.com

carla.burigatto@haemonetics.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-fourth-quarter-and-fiscal-year-2021-results-may-13-2021-301276038.html

SOURCE Haemonetics Corporation

Copyright 2021 PR Newswire

1 Year Haemonetics Chart

1 Year Haemonetics Chart

1 Month Haemonetics Chart

1 Month Haemonetics Chart

Your Recent History

Delayed Upgrade Clock